I have posted before that one has to be an eternal optimist to invest in biotechs. That's me. The question that is exercising my mind at the moment is how the company is going to raise sufficient capital to fund operations through to profitability and what impact it will have on the share price if they are successful. What will be shareholders reaction if there is a positive announcement this week and the share price rebounds. Management will certainly come in for a great deal more criticism from shareholders who sold out at a substantial loss. My rough numbers indicate that we will get through to profitability within 3 years taking in to account the revised estimates. That's my bit of dreaming for the day.
EGM update, page-103
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.22 |
Change
0.740(6.45%) |
Mkt cap ! $258.3M | |||
| Open | High | Low | Value | Volume |
| $11.50 | $12.25 | $11.49 | $395.2K | 33.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $11.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.22 | 127 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |